AbbVie just dropped an update on its Phase 3 clinical study. They're testing Lutikizumab, a potential treatment for ...

J.W. Cole Advisors Inc. significantly reduced its holdings in Amgen Inc., selling 4,695 shares, which resulted in a 28.9% ...